Table 3.
Group | 1 st day | 3 rd day | 7 th day | 10 th day | 15 th day | 20 th day | 25 th day | 30 th day |
---|---|---|---|---|---|---|---|---|
BC | 12.5±3 | 13.3±3 | 11.4±3.7 | 10.8±3 | 7.5±2.9 | 5±1.7 | 1.4±0.8 | 0.4±0.5 |
N/S | 11.8±2.4 | 12.6±2.1 | 10.6±2.7 | 9±3.1 | 6.7±2 | 4.4±2 | 1±0.8 | 0.2±0.3 |
SSD 1% | 13.3±2.5 | 13.3±2.5 | 13±1.6 | 12.6±2 | 10.5±1.6 | 5.5±1.5 | 3.1±1.3 | 1.8±0.7 |
MS 5% | 12.9±3.2 | 13.5±3 | 10±3 | 9.7±2.6 | 4.7±2 | 0.8±0.7 | 0.41±0.44 | 0 |
MS 10% | 11.6±2.4 | 12±1.9 | 8.7±1.8 | 8.4±2 | 4.5±2 | 0.4±0.5 | 0 | 0 |
p value* | 0.575 | 0.675 | 0.014 | 0.011 | 0.001 | 0.001 | 0.001 | 0.001 |
BC: Base cream, N/S: Normal saline, SSD: Silver sulfadiazine, MS: Malva sylvestris.